Amgen Financial Diagnostics

AMGN -- USA Stock  

USD 176.30  0.17  0.1%

Amgen diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 88.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.76. Amgen last dividend was issued on 2018-05-16. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people. For more info on AMGEN please contact Robert Bradway at 805-447-1000 or go to http://www.amgen.com.

Amgen Alerts

Amgen has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 88.0% of the company shares are held by institutions such as insurance companies
On May 16, 2018 Amgen paid $ 1.32 per share dividend to its current shareholders
Latest headline from standardoracle.com: Acquisition by David Meline of 4508 shares of Amgen subject to Rule 16b-3

Amgen Upcoming Events

Upcoming Quarterly ReportApril 27, 2017
Next Earnings ReportJuly 26, 2017

Amgen EPS Estimate

EPSEstimate Date
Quarterly Estimate2.99April 27, 2017

Amgen SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement

Amgen Thematic Classifications

Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Baby Boomer Prospects IdeaBaby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Giant Impact IdeaGiant Impact
Public companies with mega capitalization
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares49.1 M8.4 B
Capital Research Global InvestorsCommon Shares47 M8 B
Blackrock IncCommon Shares46.9 M8 B
Fmr LlcCommon Shares42.9 M7.3 B
State Street CorpCommon Shares27.5 M4.7 B
Primecap Management CoCommon Shares21.4 M3.7 B
Invesco LtdCommon Shares9.3 M1.6 B

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 116.32 B.

Profitablity

The company has Profit Margin (PM) of 9.67 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 54.26 % which suggests for every 100 dollars of sales it generated a net operating income of 0.54.

Management Efficiency

Amgen has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.

Stock Holders for Amgen

Information
Ratio
Value
At Risk
NasdaqNasdaq 0.28 (0.18) 
Mega LifeMega Life Science 0.00  0.00 
FMLSXWasatch LongShort Investor 0.00  0.00 
AllianzAllianz US Equity WT USD 0.00  0.00 
GamavoGamavo SICAV 0.29 (0.12) 
FidelityFidelity Advisor Health Care M 0.00  0.00 
RydexRydex Health Care H 0.00  0.00 
SPDR MSCISPDR MSCI World Health Care ETF 0.0332 (12.02) 
AmericanAmerican Funds Capital World GrInc F2 0.00  0.00 
VPMCXVanguard PRIMECAP Inv 0.00  0.00 
TempletonTempleton World A 0.00  0.00 
TempletonTempleton Growth R 0.00  0.00 
SchwabSchwab Core Equity 0.00  0.00 
SEI LargeSEI Large Cap A 0.00  0.00 
UnitedUnited Global Healthcare 0.00  0.00 
SEI LargeSEI Large Cap Value I 0.00  0.00 
RYBOXRydex Biotechnology A 0.00  0.00 
AmericanAmerican Funds Capital World GrInc R5E 0.00  0.00 
AmericanAmerican Funds Capital World GrInc R6 0.00  0.00 
AmericanAmerican Funds Capital World GrInc R3 0.00  0.00 

Technical Drivers

Amgen shows Mean Deviation of 1.01 and Risk Adjusted Performance of 0.01. Amgen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Amgen which can be compared to its rivals. Please confirm Amgen Treynor Ratio, and the relationship between Standard Deviation and Downside Variance to decide if Amgen is priced correctly providing market reflects its regular price of 176.3 per share. Given that Amgen has Jensen Alpha of 0.0, we suggest you validate Amgen prevailing market performance to make sure the company can sustain itself at future point.

Amgen Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Amgen Insider Trading Activities

Amgen Outstanding Bonds

MaturityCouponRating
031162AA8 8.125%04/01/20978.125
A
031162AV2 5.85%06/01/20175.85
A
031162AW0 6.375%06/01/20376.375
A
031162AX8 6.15%06/01/20186.15
A
031162AY6 6.9%06/01/20386.9
A
031162AZ3 5.7%02/01/20195.7
A
031162BA7 6.4%02/01/20396.4
A
031162BB5 4.5%03/15/20204.5
A
031162BC3 5.75%03/15/20405.75
A
031162BD1 3.45%10/01/20203.45
A
031162BE9 4.95%10/01/20414.95
A
031162BF6 2.3%06/15/20162.3
A
031162BG4 4.1%06/15/20214.1
A
031162BH2 5.65%06/15/20425.65
A
031162BK5 5.15%11/15/20415.15
A
031162BL3 2.5%11/15/20162.5
A
031162BM1 3.875%11/15/20213.875
A
031162BN9 3.625%05/15/20223.625
A
031162BP4 5.375%05/15/20435.375
A
031162BQ2 2.125%05/15/20172.125
A
031162BR0 1.25%05/22/20171.25
A
031162BU3 2.2%05/22/20192.2
A
031162BV1 3.625%05/22/20243.625
A
031162AS9 5.85%06/01/20175.85
A
031162BW9 2.125%05/01/20202.125
NA
031162BX7 2.7%05/01/20222.7
A
031162BY5 3.125%05/01/20253.125
A
031162BZ2 4.4%05/01/20454.4
A

Amgen Technical and Predictive Indicators

Amgen Corporate Filings

Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations

Amgen Forecast Models

Did you try this?

Run Stock Tickers Now
   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Stock Tickers
Also Currentnly Active
Purchased over 300 shares of
3 days ago
Traded for 9.556
Purchased over 100 shares of
3 days ago
Traded for 29.25
Purchased over 40 shares of
3 days ago
Traded for 64.51
Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.